Delayed Double Treatment with Adult-Sourced Adipose-Derived Mesenchymal Stem Cells Increases Striatal Medium-Spiny Neuronal Number, Decreases Striatal Microglial Number, and Has No Subventricular Proliferative Effect, After Acute Neonatal...

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2021 Aug 7

PMID 34360638

Citations 5

Authors

Haylee K Basham

Benjamin E Aghoghovwia

Panagiotis Papaioannou

Steve Seo

Dorothy E Oorschot

Affiliations

Soon will be listed here.

Abstract

Perinatal hypoxia-ischemia (HI) is a major cause of striatal injury. Delayed post-treatment with adult-sourced bone marrow-derived mesenchymal stem cells (BMSCs) increased the absolute number of striatal medium-spiny neurons (MSNs) following perinatal HI-induced brain injury. Yet extraction of BMSCs is more invasive and difficult compared to extraction of adipose-derived mesenchymal stem cells (AD-MSCs), which are easily sourced from subcutaneous tissue. Adult-sourced AD-MSCs are also superior to BMSCs in the treatment of adult ischemic stroke. Therefore, we investigated whether delayed post-treatment with adult-sourced AD-MSCs increased the absolute number of striatal MSNs following perinatal HI-induced brain injury. This included investigation of the location of injected AD-MSCs within the brain, which were widespread in the dorsolateral subventricular zone (dlSVZ) at 1 day after their injection. Cells extracted from adult rat tissue were verified to be stem cells by their adherence to tissue culture plastic and their expression of specific 'cluster of differentiation' (CD) markers. They were verified to be AD-MSCs by their ability to differentiate into adipocytes and osteocytes in vitro. Postnatal day (PN) 7/8, male Sprague-Dawley rats were exposed to either HI right-sided brain injury or no HI injury. The HI rats were either untreated (HI + Diluent), single stem cell-treated (HI + MSCs×1), or double stem cell-treated (HI + MSCs×2). Control rats that were matched-for-weight and litter had no HI injury and were treated with diluent (Uninjured + Diluent). Treatment with AD-MSCs or diluent occurred either 7 days, or 7 and 9 days, after HI. There was a significant increase in the absolute number of striatal dopamine and cyclic AMP-regulated phosphoprotein (DARPP-32)-positive MSNs in the double stem cell-treated (HI + MSCs×2) group and the normal control group compared to the HI + Diluent group at PN21. We therefore investigated two potential mechanisms for this effect of double-treatment with AD-MSCs. Specifically, did AD-MSCs: (i) increase the proliferation of cells within the dlSVZ, and (ii) decrease the microglial response in the dlSVZ and striatum? It was found that a primary repair mechanism triggered by double treatment with AD-MSCs involved significantly decreased striatal inflammation. The results may lead to the development of clinically effective and less invasive stem cell therapies for neonatal HI brain injury.

Citing Articles

Perinatal Tissue-Derived Stem Cells: An Emerging Therapeutic Strategy for Challenging Neurodegenerative Diseases.

Bruno A, Milillo C, Anaclerio F, Buccolini C, DellElice A, Angilletta I Int J Mol Sci. 2024; 25(2).

PMID: 38256050 PMC: 10815412. DOI: 10.3390/ijms25020976.

Progress in Research on Stem Cells in Neonatal Refractory Diseases.

Huang F, He Y, Zhang M, Luo K, Li J, Li J J Pers Med. 2023; 13(8).

PMID: 37623531 PMC: 10455340. DOI: 10.3390/jpm13081281.

Stem Cells Attenuate the Inflammation Crosstalk Between Ischemic Stroke and Multiple Sclerosis: A Review.

Monsour M, Gordon J, Lockard G, Borlongan C Cell Transplant. 2023; 32:9636897231184596.

PMID: 37515536 PMC: 10387781. DOI: 10.1177/09636897231184596.

A Novel Rat Model of ADHD-like Hyperactivity/Impulsivity after Delayed Reward Has Selective Loss of Dopaminergic Neurons in the Right Ventral Tegmental Area.

Kohe S, Gowing E, Seo S, Oorschot D Int J Mol Sci. 2023; 24(14).

PMID: 37511013 PMC: 10379272. DOI: 10.3390/ijms241411252.

Advances in neonatal cell therapies: Proceedings of the First Neonatal Cell Therapies Symposium (2022).

Malhotra A, Thebaud B, Paton M, Fleiss B, Papagianis P, Baker E Pediatr Res. 2023; 94(5):1631-1638.

PMID: 37380752 PMC: 10624618. DOI: 10.1038/s41390-023-02707-x.

References

Hobbs C, Oorschot D . Neonatal rat hypoxia-ischemia: long-term rescue of striatal neurons and motor skills by combined antioxidant-hypothermia treatment. Brain Pathol. 2008; 18(3):443-54. PMC: 8095613. DOI: 10.1111/j.1750-3639.2008.00146.x. View

Anjos-Afonso F, Siapati E, Bonnet D . In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J Cell Sci. 2004; 117(Pt 23):5655-64. DOI: 10.1242/jcs.01488. View

Aghoghovwia B, Goddard L, Oorschot D . Long-Term Fine Motor Capability on the Staircase Test Correlates with the Absolute Number, but Not the Density, of DARPP-Positive Neurons in the Caudate-Putamen. Anat Rec (Hoboken). 2019; 302(11):2040-2048. DOI: 10.1002/ar.24196. View

Marin-Banasco C, Suardiaz Garcia M, Hurtado Guerrero I, Maldonado Sanchez R, Estivill-Torrus G, Leyva Fernandez L . Mesenchymal properties of SJL mice-stem cells and their efficacy as autologous therapy in a relapsing-remitting multiple sclerosis model. Stem Cell Res Ther. 2014; 5(6):134. PMC: 4445793. DOI: 10.1186/scrt524. View

Lin G, Huang Y, Shindel A, Banie L, Wang G, Lue T . Labeling and tracking of mesenchymal stromal cells with EdU. Cytotherapy. 2009; 11(7):864-73. PMC: 2862589. DOI: 10.3109/14653240903180084. View

Oorschot D . Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical disector methods. J Comp Neurol. 1996; 366(4):580-99. DOI: 10.1002/(SICI)1096-9861(19960318)366:4<580::AID-CNE3>3.0.CO;2-0. View

Park D, Lee S, Bae D, Yang Y, Yang G, Kyung J . Transplantation of Human Adipose Tissue-Derived Mesenchymal Stem Cells Restores the Neurobehavioral Disorders of Rats With Neonatal Hypoxic-Ischemic Encephalopathy. Cell Med. 2016; 5(1):17-28. PMC: 4733914. DOI: 10.3727/215517913X658936. View

van Velthoven C, Kavelaars A, van Bel F, Heijnen C . Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav Immun. 2009; 24(3):387-93. DOI: 10.1016/j.bbi.2009.10.017. View

Gunn A, Gunn T, Gunning M, Williams C, Gluckman P . Neuroprotection with prolonged head cooling started before postischemic seizures in fetal sheep. Pediatrics. 1998; 102(5):1098-106. DOI: 10.1542/peds.102.5.1098. View

10.

Slomianka L, West M . Estimators of the precision of stereological estimates: an example based on the CA1 pyramidal cell layer of rats. Neuroscience. 2005; 136(3):757-67. DOI: 10.1016/j.neuroscience.2005.06.086. View

11.

DeCarolis N, Kirby E, Wyss-Coray T, Palmer T . The Role of the Microenvironmental Niche in Declining Stem-Cell Functions Associated with Biological Aging. Cold Spring Harb Perspect Med. 2015; 5(12). PMC: 4665032. DOI: 10.1101/cshperspect.a025874. View

12.

Felling R, Snyder M, Romanko M, Rothstein R, Ziegler A, Yang Z . Neural stem/progenitor cells participate in the regenerative response to perinatal hypoxia/ischemia. J Neurosci. 2006; 26(16):4359-69. PMC: 6673988. DOI: 10.1523/JNEUROSCI.1898-05.2006. View

13.

Ophelders D, Gussenhoven R, Klein L, Jellema R, Westerlaken R, Hutten M . Preterm Brain Injury, Antenatal Triggers, and Therapeutics: Timing Is Key. Cells. 2020; 9(8). PMC: 7464163. DOI: 10.3390/cells9081871. View

14.

Hobbs C, Thoresen M, Tucker A, Aquilina K, Chakkarapani E, Dingley J . Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ischemia. Stroke. 2008; 39(4):1307-13. DOI: 10.1161/STROKEAHA.107.499822. View

15.

Ong J, Plane J, Parent J, Silverstein F . Hypoxic-ischemic injury stimulates subventricular zone proliferation and neurogenesis in the neonatal rat. Pediatr Res. 2005; 58(3):600-6. DOI: 10.1203/01.PDR.0000179381.86809.02. View

16.

Ikegame Y, Yamashita K, Hayashi S, Mizuno H, Tawada M, You F . Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy. 2011; 13(6):675-85. DOI: 10.3109/14653249.2010.549122. View

17.

McRae A, Gilland E, Bona E, Hagberg H . Microglia activation after neonatal hypoxic-ischemia. Brain Res Dev Brain Res. 1995; 84(2):245-52. DOI: 10.1016/0165-3806(94)00177-2. View

18.

Archambault J, Moreira A, McDaniel D, Winter L, Sun L, Hornsby P . Therapeutic potential of mesenchymal stromal cells for hypoxic ischemic encephalopathy: A systematic review and meta-analysis of preclinical studies. PLoS One. 2017; 12(12):e0189895. PMC: 5736208. DOI: 10.1371/journal.pone.0189895. View

19.

Galvin K, Oorschot D . Postinjury magnesium sulfate treatment is not markedly neuroprotective for striatal medium spiny neurons after perinatal hypoxia/ischemia in the rat. Pediatr Res. 1998; 44(5):740-5. DOI: 10.1203/00006450-199811000-00017. View

20.

FRIEDENSTEIN A, PETRAKOVA K . Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol. 1966; 16(3):381-90. View